Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹147.51
Market cap: ₹8,083 Cr
Revenue (annual): ₹1,806 Cr
Net profit (annual): ₹94.88 Cr
P/E (TTM): 57.5×Sector 47.4×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

4 Aug 2026 13:58 IST BSE

Morepen Laboratories Investor Presentation: Key Takeaways

Morepen delivers explosive Q1'FY27 growth with 207% EBITDA jump, driven by the first commercial CDMO dispatches and operational leverage. The 'Morepen 2.0' strategy shifts focus from commodity APIs to high-margin innovation-led manufacturing.

Open call summary → Read the filing ↗

27 May 2026 08:22 IST NSE

Earnings Call

Morepen Laboratories Earnings Call: Key Takeaways

Morepen Labs reported Q4 FY26 revenue of ₹472 Cr, up 22% YoY, while shifting focus toward long-term CDMO contracts and high-margin medical devices.

Open call summary → Read the filing ↗